Molecule Details
| InChIKey | MKLKAQMPKHNQPR-NSHDSACASA-N |
|---|---|
| Compound Name | Palupiprant |
| Canonical SMILES | C[C@H](NC(=O)c1c(C(F)F)nn(C)c1Oc1cccc(C(F)(F)F)c1)c1ccc(C(=O)O)cc1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 7.06 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB21421 |
|---|---|
| Drug Name | Palupiprant |
| CAS Number | 1369489-71-3 |
| Groups | investigational |
| ATC Codes | nan |
| Description | Palupiprant is a small molecule drug. Palupiprant has a monoisotopic molecular weight of 483.12 Da. |
Categories: Acids, Carbocyclic Benzene Derivatives
Cross-references: BindingDB: 119448 CHEMBL3670685 ZINC: ZINC000114766778
Target Activities (2)
DrugBank Target Actions (1)
| Target | Gene | Target Name | Action | Type |
|---|---|---|---|---|
| P35408 | PTGER4 | Prostaglandin E2 receptor EP4 subtype | antagonist | targets |